Ç. Gerçel-Taylor

发表

ORIGINAL ARTICLE: Genistein Reverses Diminished T‐Cell Signal Transduction, Induced by Post‐Menopausal Estrogen Levels

S. Nakajima, J. Parry, Douglas D. Taylor, 2008, American journal of reproductive immunology.

cDNA Microarray Analysis of Gene Expression in Ovarian Cancer Cells After Treatment with Carboplatin and Paclitaxel

Douglas D. Taylor, Ç. Gerçel-Taylor, L. Randall-Whitis, 2006 .

Presence of aberrant tumor-reactive immunoglobulins in the circulation of patients with ovarian cancer.

D. Taylor, L. Bazzett, Ç. Gerçel-Taylor, 2001, Gynecologic oncology.

Alterations of T cell activation signalling and cytokine production by postmenopausal estrogen levels

S. Nakajima, Douglas D. Taylor, Ç. Gerçel-Taylor, 2009, Immunity & Ageing.

Identification of a human tumor-derived lipolysis-promoting factor.

D. Taylor, L. Jenis, D. Devereux, 1992, Cancer research.

Inhibitory effect of genistein and daidzein on ovarian cancer cell growth.

Douglas D. Taylor, Ç. Gerçel-Taylor, Anna K Feitelson, 2004, Anticancer research.

Modulation of CD3-zeta as a marker of clinical response to IL-2 therapy in ovarian cancer patients.

Douglas D. Taylor, R. Edwards, Ç. Gerçel-Taylor, 2004, Gynecologic oncology.

Humoral immune responses to cathepsin D and glucose-regulated protein 78 in ovarian cancer patients.

J. Shabanowitz, D. Hunt, D. Taylor, 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.

Plasma matrix metalloproteinase activity during the menstrual cycle of healthy ovulatory patients who underwent tubal ligation.

S. Nakajima, P. Lin, Ç. Gerçel-Taylor, 2005, Fertility and sterility.

Differential expression of T-cell CD3-zeta chains in patients with cervical dysplasia before and after treatment

D. Taylor, C. Helm, Ç. Gerçel-Taylor, 2006, International Journal of Gynecologic Cancer.

Ovarian Cancer-Derived Exosomal Fibronectin Induces Pro-Inflammatory IL-1β

Douglas D. Taylor, S. Atay, Ç. Gerçel-Taylor, 2013 .

Potentiation of tumor lysis by a bispecific antibody that binds to CA19-9 antigen and the Fc gamma receptor expressed by human large granular lymphocytes.

L. Weiner, Ç. Gerçel-Taylor, J. Kitson, 1990, Cancer research.

Specific Isolation of Placenta‐Derived Exosomes from the Circulation of Pregnant Women and Their Immunoregulatory Consequences 1

Douglas D. Taylor, Ç. Gerçel-Taylor, Anuradha Sabapatha, 2006, American journal of reproductive immunology.

Shed membrane fragment-associated markers for endometrial and ovarian cancers.

Douglas D. Taylor, K. Lyons, Ç. Gerçel-Taylor, 2002, Gynecologic oncology.

Shed Membrane Fragment-Associated Markers for Endometrial and Ovarian Cancers

Douglas D. Taylor, K. Lyons, Ç. Gerçel-Taylor, 2002 .

Modulation of T-cell CD3-zeta chain expression during normal pregnancy.

Douglas D. Taylor, S. Sullivan, Ç. Gerçel-Taylor, 2002, Journal of reproductive immunology.

Pregnancy-linked suppression of TcR signaling pathways by a circulating factor absent in recurrent spontaneous pregnancy loss (RPL).

Douglas D. Taylor, H. Bohler, Ç. Gerçel-Taylor, 2006, Molecular immunology.

Immune recognition of endometrial tumor antigens induced by multiparity.

D. Taylor, L. Shields, W. Katsanis, 1998, Gynecologic oncology.

Shed membrane fragment modulation of CD3-zeta during pregnancy: link with induction of apoptosis.

Douglas D. Taylor, G. Lam, S. O'Connor, 2002, Journal of reproductive immunology.

Epitope recognition by anti-cathepsin D autoantibodies in endometrial cancer patients.

D. Taylor, C. Watkins, Ç. Gerçel-Taylor, 2001, Gynecologic oncology.

Diphenylamine assay of DNA fragmentation for chemosensitivity testing.

Ç. Gerçel-Taylor, 2005, Methods in molecular medicine.

A novel approach to cancer immunotherapy: tumor cells decorated with CD80 generate effective antitumor immunity.

D. Metzinger, Douglas D. Taylor, Narendra P. Singh, 2003, Cancer research.

Inhibition of Endometrial Cancer Cell Lines by Mifepristone (RU 486)

Douglas D. Taylor, R. Gibb, T. Wan, 1998, The Journal of the Society for Gynecologic Investigation: JSGI.

Use of diphenylamine in the detection of apoptosis.

R. Gibb, Ç. Gerçel-Taylor, 2001, Methods in molecular medicine.

Lymphokine‐Activated Killer (LAK)‐Mediated Lysis of Sequentially Isolated Ovarian Cancer Cell Lines

C. Yashar, R. Gibb, D. Taylor, 1997, American journal of reproductive immunology.

Midluteal matrix metalloproteinase and tissue-inhibiting metalloproteinase plasma levels after embryo transfer.

S. Nakajima, A. Carrillo, Ç. Gerçel-Taylor, 2004, Fertility and sterility.

Modulation of TcR/CD3-zeta chain expression by a circulating factor derived from ovarian cancer patients

D. Bender, T. Whiteside, D. Taylor, 2001, British Journal of Cancer.

Alterations in T-cell signal transduction molecules associated with recurrent spontaneous pregnancy loss.

Douglas D. Taylor, Ç. Gerçel-Taylor, D. Taylor, 2004, Journal of reproductive immunology.

Enhancement of antitumor effects of combined chemoimmunotherapy.

D. Taylor, J. Weese, W. Fowler, 1993, Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy.

Altered cord serum lipid levels associated with small for gestational age infants.

D. Taylor, Ç. Gerçel-Taylor, J. Jones, 1999, Obstetrics and gynecology.

Human chorionic gonadotropin promotes tumorigenesis of choriocarcinoma JAr cells

C. Rao, Z. Lei, Ç. Gerçel-Taylor, 1999 .

Morphologic and proteomic characterization of exosomes released by cultured extravillous trophoblast cells.

M. Kesimer, S. Atay, Ç. Gerçel-Taylor, 2011, Experimental cell research.

Tumour-derived exosomes and their role in cancer-associated T-cell signalling defects

D. Taylor, Ç. Gerçel-Taylor, D. Taylor, 2005, British Journal of Cancer.

Exosomal microRNA: a diagnostic marker for lung cancer.

Douglas D. Taylor, C. Gerçel-Taylor, G. Kloecker, 2008, Clinical lung cancer.

MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer.

Cicek Gercel-Taylor, Douglas D Taylor, Ç. Gerçel-Taylor, 2008, Gynecologic oncology.

Exosome platform for diagnosis and monitoring of traumatic brain injury

Ç. Gerçel-Taylor, D. Taylor, 2014, Philosophical Transactions of the Royal Society B: Biological Sciences.

Pregnancy-Associated Exosomes and Their Modulation of T Cell Signaling1

Sibel Akyol, Douglas D. Taylor, C. Gerçel-Taylor, 2006, The Journal of Immunology.

Tumor-derived exosomes as mediators of disease and potential diagnostic biomarkers.

S. Atay, Ç. Gerçel-Taylor, Carolyn D. Roberson, 2010, Cancer biomarkers : section A of Disease markers.

Trophoblast‐Derived Exosomes Mediate Monocyte Recruitment and Differentiation

J. Suttles, G. Mor, Douglas D. Taylor, 2011, American journal of reproductive immunology.

Alterations in Antibody Subclass Immune Reactivity to Trophoblast‐derived Fetal Fibronectin and α2‐Macroglobulin in Women with Recurrent Pregnancy Loss

S. Nakajima, S. Rai, Jianmin Pan, 2012, American journal of reproductive immunology.

Aberrations in normal systemic lipid metabolism in ovarian cancer patients.

F B Kraemer, D. Taylor, D. Doering, 1996, Gynecologic oncology.

Patient-derived tumor-reactive antibodies as diagnostic markers for ovarian cancer.

L. Parker, Ç. Gerçel-Taylor, D. Taylor, 2009, Gynecologic oncology.

Cellular response to chemotherapy and radiation in cervical cancer.

C. Yashar, Ç. Gerçel-Taylor, A. Saxena, 2005, American journal of obstetrics and gynecology.

Effect of chemotherapy on the mutation frequency of ovarian cancer cells at the HPRT locus.

Ç. Gerçel-Taylor, D. Taylor, Jeremy J Scobee, 2005, Anticancer research.

Nanoparticle analysis of circulating cell-derived vesicles in ovarian cancer patients.

M. Kesimer, R. Tullis, Cicek Gercel-Taylor, 2012, Analytical biochemistry.

Potentiation of the radiation effect with genistein in cervical cancer cells.

C. Yashar, W. Spanos, Ç. Gerçel-Taylor, 2005, Gynecologic oncology.

Antitumor effects of a bispecific antibody targeting CA19-9 antigen and CD16.

L. Weiner, M. Holmes, I. Garcia de Palazzo, 1992, Cancer research.

Induction of Immune Responses to Ovarian Tumor Antigens by Multiparity

C. Gerçel-Taylor, C. Yashar, D. Taylor, 1997, The Journal of the Society for Gynecologic Investigation: JSGI.

Biomarqueurs de cancer

Ç. Gerçel-Taylor, D. Taylor, 2010 .

Characterization of humoral responses of ovarian cancer patients: antibody subclasses and antigenic components.

D. Metzinger, S. Atay, Ç. Gerçel-Taylor, 2010, Gynecologic oncology.

Exosomes/microvesicles: mediators of cancer-associated immunosuppressive microenvironments

Ç. Gerçel-Taylor, D. Taylor, 2011, Seminars in Immunopathology.

HSP-10 in ovarian cancer: expression and suppression of T-cell signaling.

S. Akyol, Ç. Gerçel-Taylor, D. Taylor, 2006, Gynecologic oncology.

T-cell apoptosis and suppression of T-cell receptor/CD3-zeta by Fas ligand-containing membrane vesicles shed from ovarian tumors.

T. Whiteside, Douglas D. Taylor, C. Gerçel-Taylor, 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

Preliminary Study of Plasma Exosomal Tau as a Potential Biomarker for Chronic Traumatic Encephalopathy

R. Cantu, R. Stern, Jing Zhang, 2016, Journal of Alzheimer's disease : JAD.

Effects of the components of hormone therapy on matrix metalloproteinases in breast-cancer cells: an in vitro study.

S. Nakajima, Ç. Gerçel-Taylor, M. Abdallah, 2007, Fertility and sterility.

Alterations in humoral immune responses associated with recurrent pregnancy loss.

S. Nakajima, D. Taylor, L. Shields, 2000, Fertility and sterility.

Loss of communication in ovarian cancer.

Cicek Gercel-Taylor, Douglas D Taylor, Chris R Toler, 2006, American journal of obstetrics and gynecology.

The origin, function, and diagnostic potential of RNA within extracellular vesicles present in human biological fluids

Ç. Gerçel-Taylor, D. Taylor, 2013, Front. Genet..

Modulation of proliferation and chemosensitivity by procathepsin D and its peptides in ovarian cancer.

C. Gerçel-Taylor, D. Taylor, L. Bazzett, 1999, Gynecologic oncology.

Cathepsin D antigenic epitopes identified by the humoral responses of ovarian cancer patients

C. Gerçel-Taylor, D. Taylor, G. Conner, 1998, Cancer Immunology, Immunotherapy.

Human Trophoblast‐Derived Exosomal Fibronectin Induces Pro‐Inflammatory Il‐1β Production by Macrophages

S. Atay, Ç. Gerçel-Taylor, D. Taylor, 2011, American journal of reproductive immunology.

Modulation of microRNA associated with ovarian cancer cells by genistein.

D. Metzinger, D. Taylor, L. Parker, 2009, European journal of gynaecological oncology.

Endometriosis Markers: Immunologic Alterations as Diagnostic Indicators for Endometriosis

B. Lessey, H. Bohler, Ç. Gerçel-Taylor, 2007, Reproductive Sciences.

Taxol-induced bcl-2 phosphorylation in ovarian cancer cell monolayer and spheroids.

R. Gibb, D. Taylor, S Makhija, 1999, International journal of oncology.

Exosome isolation for proteomic analyses and RNA profiling.

W. Zacharias, Cicek Gercel-Taylor, Douglas D Taylor, 2011, Methods in molecular biology.

Urinary matrix metalloproteinases as a potential screening test for gynecologic malignancies.

Douglas D. Taylor, C. Gerçel-Taylor, M. Magnus, 2003, Gynecologic oncology.

Comparisons of matrix metalloproteinase 1, 2, and 9 activity in periovulatory follicular fluid from natural and stimulated menstrual cycles.

S. Nakajima, P. Lin, Ç. Gerçel-Taylor, 2006, Fertility and sterility.

Gene expression profiling in response to estradiol and genistein in ovarian cancer cells.

L. Parker, S. Kesterson, Cicek Gercel-Taylor, 2009, Cancer genomics & proteomics.

Tumor-reactive immunoglobulins in ovarian cancer: diagnostic and therapeutic significance? (review).

D. Taylor, Ç. Gerçel-Taylor, 1998, Oncology reports.

Identification of Immunoreactive Tumour Antigens Using Free and Exosome-Associated Humoral Responses

K. Schey, Ç. Gerçel-Taylor, Carolyn D. Roberson, 2013, Journal of Circulating Biomarkers.

Expression and Shedding of CD44 Variant Isoforms in Patients With Gynecologic Malignancies

D. Taylor, S. Gall, Ç. Gerçel-Taylor, 1996, The Journal of the Society for Gynecologic Investigation: JSGI.

Comparison of serum vascular endothelial growth levels between patients with and without ovarian malignancies

D. Taylor, Ç. Gerçel-Taylor, K. Dehaven, 2002, International Journal of Gynecologic Cancer.

Bispecific monoclonal antibody regulation of Fc gamma RIII-directed tumor cytotoxicity by large granular lymphocytes.

L. Weiner, S. Adams, Ç. Gerçel-Taylor, 1992, Cellular immunology.

Induction of p53 and drug resistance following treatment with cisplatin or paclitaxel in ovarian cancer cell lines.

D. Metzinger, Douglas D. Taylor, C. Gerçel-Taylor, 2006, Cancer letters.

1141420984 Placental exosome suppression of T cell activation and differential target of T cell subsets

Ç. Gerçel-Taylor, DD Taylor, 2006 .

Identification of a Unique Form of p53 in Human Cord Blood Associated with the Development of Maternal Autoantibodies

C. Gerçel-Taylor, C. Yashar, R. Gibb, 1998, American journal of reproductive immunology.

Apoptosis as a measure of chemosensitivity to cisplatin and taxol therapy in ovarian cancer cell lines.

R. Gibb, D. Taylor, T. Wan, 1997, Gynecologic oncology.

Expression and shedding of CD44 variant isoforms in patients with gynecologic malignancies.

S. Gall, Ç. Gerçel-Taylor, D. Taylor, 1996 .

Alterations in Antibody Subclass Immune Reactivity to Trophoblast‐derived Fetal Fibronectin and α2‐Macroglobulin in Women with Recurrent Pregnancy Loss

S. Nakajima, S. Rai, Jianmin Pan, 2012, American journal of reproductive immunology.